Unknown

Dataset Information

0

Effect of a family and interdisciplinary intervention to prevent T2D: randomized clinical trial.


ABSTRACT: BACKGROUND:Lifestyle changes can reduce the risk of T2D; however, no study has evaluated the effect of a lifestyle intervention involving patients´ family. The aim of this study was to compare the impact of an interdisciplinary family (FI) Vs individual intervention (II) on glucose metabolism, insulin resistance (IR), pancreatic ?-cell function and cardiovascular risk markers in patients with prediabetes, as well as to measure the impact on their families' metabolic risk. METHODS:Randomized Clinical Trial (RCT) to compare the impact of FI and II on IR and pancreatic ?-cell function in subjects with prediabetes. There were 122 subjects with prediabetes (and 101 family members) randomized to FI or II. Data were collected in 2015-2016 and analyzed in 2017-2018. FI group had the support of their family members, who also received personalized diet and exercise recommendations; patients and their family members attended monthly a lifestyle enhancement program. II group received personalized diet and exercise recommendations. The follow-up was for 12?months. Glucose, IR, pancreatic ?-cell function and secondary outcomes (body composition and lipid profile) were assessed at baseline, 6 and 12?months. RESULTS:FI group improved area under the glucose curve (AUC) (from 18,597?±?2611 to 17,237?±?2792, p?=?0.004) and the Matsuda index (from 3.5?±?2.3 to 4.7?±?3.5, p?=?0.05) at 12?months. II group improved Disposition Index (from 1.5?±?0.4 to 1.9?±?0.73, p?

SUBMITTER: Vargas-Ortiz K 

PROVIDER: S-EPMC6977289 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Lifestyle changes can reduce the risk of T2D; however, no study has evaluated the effect of a lifestyle intervention involving patients´ family. The aim of this study was to compare the impact of an interdisciplinary family (FI) Vs individual intervention (II) on glucose metabolism, insulin resistance (IR), pancreatic β-cell function and cardiovascular risk markers in patients with prediabetes, as well as to measure the impact on their families' metabolic risk.<h4>Methods</h4>  ...[more]

Similar Datasets

| S-EPMC7233282 | biostudies-literature
| S-EPMC3050704 | biostudies-literature
| S-EPMC3267736 | biostudies-literature
| S-EPMC3751685 | biostudies-literature
| S-EPMC6791527 | biostudies-literature
| S-EPMC10372378 | biostudies-literature
| S-EPMC7907495 | biostudies-literature
2010-08-17 | E-GEOD-14700 | biostudies-arrayexpress
| S-EPMC7349967 | biostudies-literature